0.523
12.82%
-0.0769
After Hours:
1.50
0.977
+186.81%
Novo Integrated Sciences Inc stock is currently priced at $0.523, with a 24-hour trading volume of 1.53M.
It has seen a -12.82% decreased in the last 24 hours and a +11.68% rose in the past month.
The chart indicates a potential bearish trend, as the stock is below the $0.5933 pivot point. If it approaches the $0.5133 support level, significant changes may occur.
Previous Close:
$0.5999
Open:
$0.63
24h Volume:
1.53M
Market Cap:
$9.97M
Revenue:
$13.04M
Net Income/Loss:
$-13.96M
P/E Ratio:
-0.5505
EPS:
-0.95
Net Cash Flow:
$-4.12M
1W Performance:
+0.77%
1M Performance:
+11.68%
6M Performance:
+75.50%
1Y Performance:
+264.97%
Novo Integrated Sciences Inc Stock (NVOS) Company Profile
Name
Novo Integrated Sciences Inc
Sector
Industry
Phone
206 617 9797
Address
11120 NE 2nd Street, Suite 100, Bellevue
Novo Integrated Sciences Inc Stock (NVOS) Latest News
Why Rallybio Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket
Benzinga
Why Toast Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Benzinga
Why Fortinet Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Benzinga
Why DigitalOcean Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
Benzinga
Novo Integrated Sciences Inc Stock (NVOS) Financials Data
Novo Integrated Sciences Inc (NVOS) Revenue 2024
NVOS reported a revenue (TTM) of $13.04 million for the quarter ending November 30, 2023, a +8.74% rise year-over-year.
Novo Integrated Sciences Inc (NVOS) Net Income 2024
NVOS net income (TTM) was -$13.96 million for the quarter ending November 30, 2023, a +60.09% increase year-over-year.
Novo Integrated Sciences Inc (NVOS) Cash Flow 2024
NVOS recorded a free cash flow (TTM) of -$4.12 million for the quarter ending November 30, 2023, a +24.77% increase year-over-year.
Novo Integrated Sciences Inc (NVOS) Earnings per Share 2024
NVOS earnings per share (TTM) was -$1.08 for the quarter ending November 30, 2023, a +90.80% growth year-over-year.
About Novo Integrated Sciences Inc
Novo Integrated Sciences, Inc., together with its subsidiaries, provides multidisciplinary primary health care related products and services. It operates through two segments, Healthcare Services, and Product Manufacturing and Development. The company offers physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury/neurological rehabilitation, kinesiology, vestibular therapy, concussion management and baseline testing, trauma sensitive yoga and meditation for concussion-acquired brain injury and occupational stress-PTSD, women's pelvic health program, sports medicine therapy, assistive devices, dietitian, holistic nutrition, fall prevention education, sports team conditioning program, and private personal training services. It also engages in the assessment, diagnosis, treatment, pain management, rehabilitation, education, and prevention of various orthopedic, musculoskeletal, sports injury, and neurological conditions across various demographics, including pediatric, adult, and geriatric populations. In addition, the company offers eldercare physiotherapy services, such as long-term care homes, retirement homes, community based home care physiotherapy, community based group exercise classes and fall prevention programs, and community-based outpatient clinics; and elderly occupational therapy services for retirement home and community, and long-term care sectors. Further, it offers medical technology services, such as telemedicine and remote patient monitoring; and develops and distributes personalized health and wellness product solutions. The company operates 16 owned clinics. The company was incorporated in 2000 and is based in Bellevue, Washington. Novo Integrated Sciences, Inc. operates as a subsidiary of ALMC-ASAP Holdings, Inc.
Cap:
|
Volume (24h):